Expression of Concern: Emodin alleviates chronic constriction injury-induced neuropathic pain and inflammation via modulating PPAR-gamma pathway
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPain Mechanisms and Treatments · Pharmacology and Obesity Treatment · Pharmacological Effects of Natural Compounds
After this article [1] was published, the following concerns were noted:
Reference 21 is replaced with [2].
The article’s Data Availability statement was incorrect and is updated to: All relevant data are available from the authors upon request.
In light of the cumulative issues, the PLOS One Editors issue this Expression of Concern.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Badshah I, Qazi NG, Ali F, Minhas AM, Alvi AM, Kandeel M, et al. Emodin alleviates chronic constriction injury-induced neuropathic pain and inflammation via modulating PPAR-gamma pathway. P Lo S One. 2023;18(7):e 0287517. doi: 10.1371/journal.pone.0287517 37440558 PMC 10343023 · doi ↗ · pubmed ↗
- 2Im JH, Yeo IJ, Hwang CJ, Lee KS, Hong JT. PE Gylated erythropoietin protects against brain injury in the MCAO-induced stroke model by blocking NF-κB activation. Biomol Ther (Seoul). 2020;28(2):152–62. doi: 10.4062/biomolther.2019.147 31813204 PMC 7059808 · doi ↗ · pubmed ↗